1,298
Views
9
CrossRef citations to date
0
Altmetric
Original Article

Antileishmanial activity evaluation of bis-lawsone analogs and DNA topoisomerase-I inhibition studies

, , , &
Pages 185-189 | Received 10 Sep 2012, Accepted 07 Jan 2013, Published online: 27 Mar 2013

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Garima Sharma, S. Vasanth Kumar & Habibah A. Wahab. (2018) Molecular docking, synthesis, and biological evaluation of naphthoquinone as potential novel scaffold for H5N1 neuraminidase inhibition. Journal of Biomolecular Structure and Dynamics 36:1, pages 233-242.
Read now

Articles from other publishers (8)

Nawal Kishore Sahu, Ritu Sharma, Kshirsagar Prasad Suhas, Jyoti Joshi, Kunal Prakash, Richa Sharma, Ramendra Pratap, Xiwen Hu, Sukhbir Kaur, Mukesh Jain, Carmine Coluccini, Paolo Coghi & Sandeep Chaudhary. (2023) Natural-Product-Inspired Microwave-Assisted Synthesis of Novel Spirooxindoles as Antileishmanial Agents: Synthesis, Stereochemical Assignment, Bioevaluation, SAR, and Molecular Docking Studies. Molecules 28:12, pages 4817.
Crossref
Rafaella de Miranda Villarim Meira, Sara Lins da Silva Gomes, Edgar Schaeffer, Thayssa Da Silva, Andréia Carolinne de Souza Brito, Larissa Moreira Siqueira, Job Domingos Inácio, Elmo Eduardo Almeida-Amaral, Alda Maria Da-Cruz, Milla Bezerra-Paiva, Renata Heisler Neves, Luciana Silva Rodrigues, Patricia Maria Lourenço Dutra, Paulo Roberto Ribeiro Costa, Alcides José Monteiro da Silva & Silvia Amaral Gonçalves Da-Silva. (2023) Low doses of 3-phenyl-lawsone or meglumine antimoniate delivery by tattooing route are successful in reducing parasite load in cutaneous lesions of Leishmania (Viannia) braziliensis-infected hamsters. Frontiers in Cellular and Infection Microbiology 13.
Crossref
Olalla Barreiro-Costa, Cristina Quiroga Lozano, Erika Muñoz, Patricio Rojas-Silva, Andrea Medeiros, Marcelo A. Comini & Jorge Heredia-Moya. (2022) Evaluation of the Anti-Leishmania mexicana and -Trypanosoma brucei Activity and Mode of Action of 4,4′-(Arylmethylene)bis(3-methyl-1-phenyl-1H-pyrazol-5-ol). Biomedicines 10:8, pages 1913.
Crossref
Huseyin Istanbullu & Gulsah Bayraktar. 2022. Leishmaniasis - General Aspects of a Stigmatized Disease. Leishmaniasis - General Aspects of a Stigmatized Disease.
Olalla Barreiro-Costa, Gabriela Morales-Noboa, Patricio Rojas-Silva, Eliana Lara-Barba, Javier Santamaría-Aguirre, Natalia Bailón-Moscoso, Juan Carlos Romero-Benavides, Ana Herrera, Cristina Cueva, Lenin Ron-Garrido, Ana Poveda & Jorge Heredia-Moya. (2021) Synthesis and Evaluation of Biological Activities of Bis(spiropyrazolone)cyclopropanes: A Potential Application against Leishmaniasis. Molecules 26:16, pages 4960.
Crossref
Luíza Dantas-Pereira, Edézio F. Cunha-Junior, Valter V. Andrade-Neto, John F. Bower, Guilherme A.M. Jardim, Eufrânio N. da Silva Júnior, Eduardo C. Torres-Santos & Rubem F.S. Menna-Barreto. (2021) Naphthoquinones and Derivatives for Chemotherapy: Perspectives and Limitations of their Anti-trypanosomatids Activities. Current Pharmaceutical Design 27:15, pages 1807-1824.
Crossref
Razieh Ghodsi, Morteza Safarnejad, Sina Omid Malayeri & Sima Golmakanion. (2018) 3,3′-(Arylmethylene)bis(2-hydroxynaphthalene-1,4-dione) as the Main Product of the Mannich Reaction of 2-Hydroxy-1,4-Naphthoquinone with 4 H -1,2,4-Triazol-4-Amine and Various Aldehydes . Journal of Chemical Research 42:4, pages 224-226.
Crossref
Sunita Salunke-Gawali, Eulália Pereira, Umar Ali Dar & Sujit Bhand. (2017) Metal complexes of hydroxynaphthoquinones: Lawsone, bis-lawsone, lapachol, plumbagin and juglone. Journal of Molecular Structure 1148, pages 435-458.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.